The recent rise in Covid cases once again benefited sales of ivermectin and hydroxychloroquine, medicines from the so-called Covid kit, which are not effective against the disease, but were recommended by President Jair Bolsonaro (PL) during the pandemic.
The biggest jump was that of ivermectin, a vermifuge for scabies and lice, which soared from a level of 795,000 units in October to almost 1.8 million in November, according to data from Iqvia consultancy, which monitors pharmaceutical retail.
Since the beginning of the pandemic, the race for the product in pharmacies has always accelerated in times of new waves of Covid. It hit 5.5 million units sold in January, on the occasion of the arrival of omicron.
In a similar trajectory, sales of hydroxychloroquine, indicated for the treatment of malaria, rose from 89.6 thousand units in October to almost 97.5 thousand in November. The numbers have been falling since the last peak in June.
The new wave of demand for medicines from the Covid kit rekindles a bitter subject in the sector, the lack of supervision in the sale of red stripe medicines without a medical prescription, which may have facilitated the consumption of products such as chloroquine and ivermectin, boosting the revenue of drug manufacturers. products without effectiveness for the purpose of the consumer.
I have over 10 years of experience working in the news industry. I have worked for several different news organizations, including a large news website like News Bulletin 247. I am an expert in the field of economics and have written several books on the subject. I am a highly skilled writer and editor, and have a strong knowledge of social media. I am a highly respected member of the news industry, and my work has been featured in many major publications.
